VIRAMAL LIMITED

08485006
Active London

Research and experimental development on biotechnology

11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
V

VIRAMAL LIMITED

08485006

Research and experimental development on biotechnology

Founded 12 Apr 2013 Active London, England 11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Nov 2025 Next due 30 Nov 2026 5 months remaining
Confirmation Submitted 31 Mar 2026 Next due 16 Mar 2027 9 months remaining
Net assets £1M £22K 2024 year on year
Total assets £2M £39K 2024 year on year
Total Liabilities £773K £62K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

167-169 Great Portland Street 5th Floor London W1W 5PF England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for VIRAMAL LIMITED (08485006), an active life sciences and medical technology company based in London, England. Incorporated 12 Apr 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Mar → 28 Feb 2025
Type unaudited-abridged
Next accounts 28 Feb 2026
Due by 30 Nov 2026 5 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£85.04k

Increased by £27.88k (+49%)

Net Assets

£1.36M

Increased by £22.32k (+2%)

Total Liabilities

£773.26k

Decreased by £61.62k (-7%)

Turnover

N/A

Employees

11

Decreased by 2 (-15%)

Debt Ratio

36%

Decreased by 2 (-5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
28 Feb Year End
2024
29 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 3Apr 2016Series A, Seed
Investor 1Mar 2018Series A
Investor 2Mar 2018Series A

Share Capital

Share Capital

Share allotments and capital structure

38 Allotments 54,216,468 Shares £503363.14m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Oct 20258,333£5k£0.6
27 Oct 202533,333£20k£0.6
27 Oct 202516,666£10k£0.6
21 Feb 20258,333£5k£0.6
1 Sept 2024699,994£420k£0.6

Officers

Officers

2 active 1 resigned
Status
Fiore, Simona, DrDirectorItalianEngland5627 Mar 2020Active
Synett, Jonathan StuartDirectorBritishEngland4925 Apr 2016Active

Shareholders

Shareholders (272)

Oliver Stephen Bates
13.6%
7,717,140
Nina Larsen
10.3%
5,845,020

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

VIRAMAL LIMITED Current Company
BIGEL LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 Mar 2026Confirmation StatementConfirmation statement made on 2 Mar 2026 with updates
30 Mar 2026CapitalAllotment of shares (GBP 568,391.24) on 27 Oct 2025
30 Mar 2026CapitalAllotment of shares (GBP 568,391.24) on 21 Feb 2025
30 Mar 2026CapitalAllotment of shares (GBP 568,557.9) on 27 Oct 2025
30 Mar 2026CapitalAllotment of shares (GBP 567,974.58) on 27 Oct 2025
31 Mar 2026 Confirmation Statement

Confirmation statement made on 2 Mar 2026 with updates

30 Mar 2026 Capital

Allotment of shares (GBP 568,391.24) on 27 Oct 2025

30 Mar 2026 Capital

Allotment of shares (GBP 568,391.24) on 21 Feb 2025

30 Mar 2026 Capital

Allotment of shares (GBP 568,557.9) on 27 Oct 2025

30 Mar 2026 Capital

Allotment of shares (GBP 567,974.58) on 27 Oct 2025

Recent Activity

Latest Activity

Confirmation statement made on 2 Mar 2026 with updates

2 months ago on 31 Mar 2026

Allotment of shares (GBP 568,391.24) on 27 Oct 2025

2 months ago on 30 Mar 2026

Allotment of shares (GBP 568,391.24) on 21 Feb 2025

2 months ago on 30 Mar 2026

Allotment of shares (GBP 568,557.9) on 27 Oct 2025

2 months ago on 30 Mar 2026

Allotment of shares (GBP 567,974.58) on 27 Oct 2025

2 months ago on 30 Mar 2026